Celgene International Sàrl Company Profile

09:17 EDT 18th September 2018 | BioPortfolio

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the Company's website at

News Articles [852 Associated News Articles listed on BioPortfolio]


Celgene investors should visit us at call to speak to our claim center toll-free at (844) 367-9658.   About the L...

Celgene Announces Additional Results From RELEVANCE

SUMMIT (dpa-AFX) - Celgene Corp. (CELG) announced additional results from RELEVANCE, a phase III, randomized, open-label, international clinical study conducted in partnership with the Lymphoma Ac...

Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R2) Versus Rituximab ...

Celgene

CELGENE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing in Celgene Corporation to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Celgene Corporation ("Celgene" or the "Company") ...

Celgene Seeing Significant Weakness In Afternoon Trading

SUMMIT (dpa-AFX) - Shares of Celgene (CELG) have moved sharply lower during trading on Wednesday, with the biotechnology company slumping by 7.5 percent. Celgene hit its lowest intraday level in o...

Celgene-Aktie: Sind die 65 Millionen US-Dollar für Evotec gut angelegt?

In meiner gestrigen Analyse zu Evotec berichtete ich bereits über die Zusammenarbeit zwischen dem Hamburger Biotechunternehmen und Celgene. Zwar erhält Celgene bei dem Deal die exklusiven Rechte zu....

Vividion Lands $101M from Celgene to Develop Protein-Targeting Drugs

Vividion Therapeutics is partnering with Celgene to develop new drugs that modulate protein levels as a way of treating disease. Celgene (NASDAQ: CELG) will pay San Diego-based Vividion $101 million u...

Celgene and Vividion partner to develop protein-targeting drugs

Under a four-year partnership, Vividion Therapeutics Inc. agreed to use its proteomics technologies to discover potential new oncology, neurology, and inflammatory disease drug candidates for Celgene ...

Drugs and Medications [427 Associated Drugs and Medications listed on BioPortfolio]

Pvp iodine prep pad [Professional Disposables International, Inc.]

Drug Facts

Sani professional brand sani-hands for kids [Profesional Disposables International, Inc.]


Muscle and joint vanishing scent [LIFElabs, a Division of Atico International USA, INC.]

LIFElabs, a Division of Atico International USA, INC.

Sani-hands [Professional Disposables International, Inc.]


Pdi sani-hands for kids [Professional Disposables International, Inc.]


PubMed Articles [482 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

18th International Congress on Infectious Diseases/XVIII Congreso SADI 2018 - It takes two to Tango.

Respiratory Management of Extremely Preterm Infants: An International Survey.

There are significant international variations in chronic lung disease rates among very preterm infants yet there is little data on international variations in respiratory strategies.

Cohort Profile: The International Mobility In Aging Study (IMIAS).

International assessment of inter- and intrarater reliability of the International Frontal Sinus Anatomy Classification system.

Inconsistencies in the nomenclature of structures of the frontal sinus have impeded the development of a validated "reference standard" classification system that surgeons can reliably agree upon. The...

Clinical Trials [1019 Associated Clinical Trials listed on BioPortfolio]

Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult subjects exposed to Gene-modified (GM) T cell therapy participating in a p...

Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

Multi-center, survival data collection in subjects previously enrolled in Celgene Protocol CC-5013-MDS-003.

A Study to Evaluate Long-term Safety in Subjects With Solid Tumors and Hematological Disorders.

Rollover study supporting solid tumor and hematological disorder indications from Celgene sponsored CC-486 protocols eligible for participation in the study.

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome

To allow patients with HIV-associated wasting to receive thalidomide treatment at 1 of 2 doses. To gain safety and efficacy data from a broader base of patients with HIV-associated wasting...

Epidogs International Inventory of Seizure Alert Dogs

This international research project looks at the reliability of canine seizure alerting behaviour in epilepsy patients. In the first stage an international database to identify the size an...

Companies [1301 Associated Companies listed on BioPortfolio]

Celgene Cellular Therapeutics

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. ...

Celgene International Sàrl

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. C...

Celgene Corporation

Celgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.Celgene's medical research and devel...

Celgene Corporation and BeiGene, Ltd.

Celgene Corporation and Agios Pharmaceuticals, Inc.

More Information about "Celgene International Sàrl" on BioPortfolio

We have published hundreds of Celgene International Sàrl news stories on BioPortfolio along with dozens of Celgene International Sàrl Clinical Trials and PubMed Articles about Celgene International Sàrl for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celgene International Sàrl Companies in our database. You can also find out about relevant Celgene International Sàrl Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Corporate Database Quicklinks

Searches Linking to this Company Record